These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 26166558)
1. Overexpression of Lysine-Specific Demethylase 1 Is Associated With Tumor Progression and Unfavorable Prognosis in Chinese Patients With Endometrioid Endometrial Adenocarcinoma. Liu YD; Dai M; Yang SS; Xiao M; Meng FL; Chen XW Int J Gynecol Cancer; 2015 Oct; 25(8):1453-60. PubMed ID: 26166558 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer. Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of MMSET in endometrial cancer: a clinicopathologic study. Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632 [TBL] [Abstract][Full Text] [Related]
4. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma. Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972 [TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification. Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer. Zhao J; Liu T; Yu G; Wang J Tumour Biol; 2015 Feb; 36(2):1299-306. PubMed ID: 25355598 [TBL] [Abstract][Full Text] [Related]
7. Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer. Jie D; Zhongmin Z; Guoqing L; Sheng L; Yi Z; Jing W; Liang Z Dig Dis Sci; 2013 Jun; 58(6):1581-9. PubMed ID: 23314859 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study. Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096 [TBL] [Abstract][Full Text] [Related]
9. Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression. Agboyibor C; Dong J; Effah CY; Drokow EK; Pervaiz W; Li D; Kang L; Ma X; Li J; Liu Z; Liu HM Cancer Control; 2021; 28():10732748211051557. PubMed ID: 34802287 [TBL] [Abstract][Full Text] [Related]
10. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer. Yuan C; Li Z; Qi B; Zhang W; Cheng J; Wang Y J Oral Pathol Med; 2015 Feb; 44(2):159-65. PubMed ID: 25040359 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB. Han KH; Kim HS; Lee M; Chung HH; Song YS Medicine (Baltimore); 2017 May; 96(21):e6976. PubMed ID: 28538399 [TBL] [Abstract][Full Text] [Related]
12. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment. Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR Int J Gynecol Cancer; 2013 Nov; 23(9):1620-8. PubMed ID: 24126219 [TBL] [Abstract][Full Text] [Related]
13. Preoperative prediction of deep myometrial invasion and tumor grade for stage I endometrioid adenocarcinoma: a simple method of measurement on DWI. Yan B; Liang X; Zhao T; Niu C; Ding C; Liu W Eur Radiol; 2019 Feb; 29(2):838-848. PubMed ID: 30039225 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study. Zhu J; Wen H; Bi R; Wu X J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439 [TBL] [Abstract][Full Text] [Related]
15. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer. Song H; Li C; Lu R; Zhang Y; Geng J Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225 [TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating dendritic cells may be used as clinicopathologic prognostic factors in endometrial carcinoma. Lijun Z; Xin Z; Danhua S; Xiaoping L; Jianliu W; Huilan W; Lihui W Int J Gynecol Cancer; 2012 Jun; 22(5):836-41. PubMed ID: 22617481 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma. Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100 [TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma. Ni J; Zhu T; Zhao L; Che F; Chen Y; Shou H; Yu A Clin Transl Oncol; 2015 Oct; 17(10):835-9. PubMed ID: 26260911 [TBL] [Abstract][Full Text] [Related]
19. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression. Banas T; Pitynski K; Okon K; Winiarska A BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556 [TBL] [Abstract][Full Text] [Related]
20. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]